JP2017501154A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501154A5
JP2017501154A5 JP2016539318A JP2016539318A JP2017501154A5 JP 2017501154 A5 JP2017501154 A5 JP 2017501154A5 JP 2016539318 A JP2016539318 A JP 2016539318A JP 2016539318 A JP2016539318 A JP 2016539318A JP 2017501154 A5 JP2017501154 A5 JP 2017501154A5
Authority
JP
Japan
Prior art keywords
angiotensin
rate
catecholamine
norepinephrine
mcg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501154A (ja
JP6824739B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/071186 external-priority patent/WO2015095535A1/en
Publication of JP2017501154A publication Critical patent/JP2017501154A/ja
Publication of JP2017501154A5 publication Critical patent/JP2017501154A5/ja
Application granted granted Critical
Publication of JP6824739B2 publication Critical patent/JP6824739B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539318A 2013-12-18 2014-12-18 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ Active JP6824739B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US61/917,576 2013-12-18
US201461955706P 2014-03-19 2014-03-19
US61/955,706 2014-03-19
PCT/US2014/071186 WO2015095535A1 (en) 2013-12-18 2014-12-18 Angiotensin ii alone or in combination for the treatment of hypotension

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019153144A Division JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Publications (3)

Publication Number Publication Date
JP2017501154A JP2017501154A (ja) 2017-01-12
JP2017501154A5 true JP2017501154A5 (enExample) 2018-02-08
JP6824739B2 JP6824739B2 (ja) 2021-02-03

Family

ID=53367119

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016539318A Active JP6824739B2 (ja) 2013-12-18 2014-12-18 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2019153144A Active JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022113327A Withdrawn JP2022137224A (ja) 2013-12-18 2022-07-14 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2025078759A Pending JP2025114753A (ja) 2013-12-18 2025-05-09 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019153144A Active JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022113327A Withdrawn JP2022137224A (ja) 2013-12-18 2022-07-14 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2025078759A Pending JP2025114753A (ja) 2013-12-18 2025-05-09 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Country Status (25)

Country Link
US (7) US9220745B2 (enExample)
EP (2) EP2986308B1 (enExample)
JP (4) JP6824739B2 (enExample)
KR (4) KR20230051721A (enExample)
CN (4) CN111920939A (enExample)
AU (3) AU2014364528C1 (enExample)
BR (1) BR112016013961A2 (enExample)
CA (1) CA2933601A1 (enExample)
CY (1) CY1122604T1 (enExample)
DK (2) DK2986308T3 (enExample)
EA (1) EA037823B1 (enExample)
ES (2) ES3055611T3 (enExample)
FI (1) FI3607962T3 (enExample)
HR (2) HRP20251406T1 (enExample)
HU (1) HUE047062T2 (enExample)
IL (1) IL246162B (enExample)
LT (2) LT2986308T (enExample)
MX (2) MX380968B (enExample)
NZ (1) NZ721089A (enExample)
PL (2) PL3607962T3 (enExample)
PT (2) PT3607962T (enExample)
RS (2) RS59804B1 (enExample)
SI (2) SI2986308T1 (enExample)
SM (2) SMT202000018T1 (enExample)
WO (1) WO2015095535A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
EP3381465A1 (en) * 2014-07-08 2018-10-03 La Jolla Pharmaceutical Company Methods for treating hypotension
WO2016153558A1 (en) 2015-03-20 2016-09-29 Atkinson Arthur J Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
PL3400000T3 (pl) 2016-01-07 2024-04-22 La Jolla Pharma, Llc Sposoby podawania angiotensyny ii
WO2017120440A1 (en) * 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) * 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法
US20250366467A1 (en) * 2022-06-15 2025-12-04 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
JP2025538841A (ja) * 2022-12-12 2025-11-28 プロレタリアート セラピューティクス， インコーポレイテッド 心損傷を処置する方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
CA2448051A1 (en) 2001-06-04 2002-12-12 Human Genome Sciences, Inc. Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
JP2007510643A (ja) 2003-11-06 2007-04-26 ジーイー・ヘルスケア・アクスイェ・セルスカプ 医薬化合物
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
EP1942985B1 (en) 2005-09-29 2011-04-27 Fibrogen, Inc. Methods for reducing blood pressure
WO2007076572A1 (en) 2005-12-30 2007-07-12 Howard Florey Institute Of Experimental Physiology And Medicine A method of treatment
EP2029137A2 (en) 2006-06-15 2009-03-04 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
CA2678131A1 (en) 2006-11-17 2008-05-22 Antoine Andremont Colonic delivery using zn/pectin beads with a eudragit coating.
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
AU2009319856A1 (en) 2008-11-28 2010-06-03 Abbvie Inc. Stable antibody compositions and methods for stabilizing same
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
BR112013000744A2 (pt) 2010-07-14 2020-07-14 Cumberland Emerging Technologies, Inc uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
JP6522584B2 (ja) 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ 腎不全を処置するための組成物及び方法
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
EP3381465A1 (en) 2014-07-08 2018-10-03 La Jolla Pharmaceutical Company Methods for treating hypotension
WO2017120440A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
PL3400000T3 (pl) 2016-01-07 2024-04-22 La Jolla Pharma, Llc Sposoby podawania angiotensyny ii
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法

Similar Documents

Publication Publication Date Title
JP2017501154A5 (enExample)
EP4233861A3 (en) Compositions for treatment of essential tremor
JP2022009125A5 (enExample)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
NZ598534A (en) Dosage regimen of an s1p receptor modulator
JP2016516016A5 (enExample)
RU2014141893A (ru) Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
RU2018121615A (ru) Модуляторы активности комплемента
PH12016501357A1 (en) Pharmaceutical preparation containing pyridylamino acetic acid compound
JP2018526460A5 (enExample)
RU2013123646A (ru) Комбинированная композиция
JP2017519799A5 (enExample)
EP4700016A3 (en) Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
JP2019507786A5 (enExample)
JP2016510040A5 (enExample)
JP2019535830A5 (enExample)
RU2016103098A (ru) Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii
JP2015512923A5 (enExample)
RU2012116226A (ru) Бронхолитическое средство на основе простагландина
NZ708511A (en) Methods for controlling blood pressure and reducing dyspnea in heart failure
JP2015535258A5 (enExample)
JP2016503406A5 (enExample)
JP2016510738A5 (enExample)